{"id":783574,"date":"2023-09-12T18:07:42","date_gmt":"2023-09-12T22:07:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/"},"modified":"2023-09-12T18:07:42","modified_gmt":"2023-09-12T22:07:42","slug":"exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/","title":{"rendered":"Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN DIEGO, California, Sept.  12, 2023  (GLOBE NEWSWIRE) &#8212; Exagen Inc.\u00a0(Nasdaq: XGN),\u00a0a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor Fitzgerald Global Healthcare Conference, which takes place September 26-28, 2023, at the InterContinental Barclay Hotel in New York City. John Aballi, Exagen\u2019s President and Chief Executive Officer and Kamal Adawi, Exagen\u2019s Chief Financial Officer, will participate in a panel discussion on Tuesday, September 26<sup>th<\/sup>, at 8:45 AM ET. Interested parties may access the webcast of the presentation using a link on Exagen\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dt_zGOAmK7ojUmJDENLage_SndyWEjNjGTJ7n3FbfhxCLnrpsW7NHZ_SlQuwmbi4lD8Y6hD7fKPIQiUzwXTZeYf3YUj3pd5YGHnKxZDSv0-ryfoEQkmkn641mgQHtQk7\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.exagen.com\/events<\/a>.<\/p>\n<p>\n        <strong>About\u00a0Exagen Inc.<\/strong>\n      <\/p>\n<p>Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients\u2019 clinical outcomes. Exagen is located in San Diego County, California.<\/p>\n<p>For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0s78ANCSBdxAoYqiTeWvtpzHK0S-1099eZiKRgmlgzzUqBxGNA6ZZprBhU7C9ugEOWsslqv_tKMyADZuKAv4z1xAEK3WMtG941MtjyXvYDgKwLzjlrq-9U3FrhjRE3wJPHilTrfhNLNudHn0bIbIrN9l_VL5yafrt9h4-INRn5-H82YBqJwtnWh8aN2Ed-wiJATbmbK_mP1i2y_RJOtP1BxupULLdFW0uq51zedII8A=\" rel=\"nofollow noopener\" target=\"_blank\">Exagen.com<\/a>\u00a0and follow\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QXcPjsWy2w1Ph6fuWy8fEQWys6X7mmFns2bj56Q90nuAIJ0e5mVNmroItt-NSDRVnriY--y06KCTy1P0eAswX_14N3uM3rNhfVWKln7SxDd-XueN0VcE47HddJ5EsA7l6PdS8JM__-djzEhW3P1MOxWKx2X3ga5FdLQox1QXo1bJtRR1ngbC0dvzepFQwpUr8_G91ydEmtYelbUCl2QaP1rRGHTL5PoSHIy4_GLF6ws=\" rel=\"nofollow noopener\" target=\"_blank\">@ExagenInc<\/a>\u00a0on Twitter.<\/p>\n<p>\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>Exagen Inc. <br \/>Ryan Douglas<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2Bki-ymo87Y5UA_0CVyV-RVMCG5oOExR5DiMzEvijPRB-assFtRCTN_juijEg5GO9zYWtZBb485Vo3coWuAFnpRwjiQB6AQPO9MbY_UotRk=\" rel=\"nofollow noopener\" target=\"_blank\">rdouglas@exagen.com<\/a>\u00a0<br \/>760.560.1525<\/p>\n<p>\n        <strong>Company<\/strong><br \/>\n        <br \/>Exagen Inc.<br \/>Kamal Adawi, Chief Financial Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NP0XgBpUJ5FeOvgNPkrbK-jbFzAlEHkBERvBjas8GlCiWtGtcktlnCRyJTUKe3t92rd2lHv06o_Svo6PM8ui89SCWGL1Wj-bumWuxvkKKIo=\" rel=\"nofollow noopener\" target=\"_blank\">kadawi@exagen.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTAzOCM1ODExMTM0IzIwMTA5NzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YTVjYWMzZDQtNDA2Zi00NDQyLTlkMDctODA1ZDBhNzI0MjRmLTEwMjI1NDU=\/tiny\/Exagen-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, California, Sept. 12, 2023 (GLOBE NEWSWIRE) &#8212; Exagen Inc.\u00a0(Nasdaq: XGN),\u00a0a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor Fitzgerald Global Healthcare Conference, which takes place September 26-28, 2023, at the InterContinental Barclay Hotel in New York City. John Aballi, Exagen\u2019s President and Chief Executive Officer and Kamal Adawi, Exagen\u2019s Chief Financial Officer, will participate in a panel discussion on Tuesday, September 26th, at 8:45 AM ET. Interested parties may access the webcast of the presentation using a link on Exagen\u2019s website at https:\/\/investors.exagen.com\/events. About\u00a0Exagen Inc. Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-783574","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, California, Sept. 12, 2023 (GLOBE NEWSWIRE) &#8212; Exagen Inc.\u00a0(Nasdaq: XGN),\u00a0a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor Fitzgerald Global Healthcare Conference, which takes place September 26-28, 2023, at the InterContinental Barclay Hotel in New York City. John Aballi, Exagen\u2019s President and Chief Executive Officer and Kamal Adawi, Exagen\u2019s Chief Financial Officer, will participate in a panel discussion on Tuesday, September 26th, at 8:45 AM ET. Interested parties may access the webcast of the presentation using a link on Exagen\u2019s website at https:\/\/investors.exagen.com\/events. About\u00a0Exagen Inc. Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of &hellip; Continue reading &quot;Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-12T22:07:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTAzOCM1ODExMTM0IzIwMTA5NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference\",\"datePublished\":\"2023-09-12T22:07:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/\"},\"wordCount\":180,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMTAzOCM1ODExMTM0IzIwMTA5NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/\",\"name\":\"Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMTAzOCM1ODExMTM0IzIwMTA5NzI=\",\"datePublished\":\"2023-09-12T22:07:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMTAzOCM1ODExMTM0IzIwMTA5NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMTAzOCM1ODExMTM0IzIwMTA5NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk","og_description":"SAN DIEGO, California, Sept. 12, 2023 (GLOBE NEWSWIRE) &#8212; Exagen Inc.\u00a0(Nasdaq: XGN),\u00a0a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor Fitzgerald Global Healthcare Conference, which takes place September 26-28, 2023, at the InterContinental Barclay Hotel in New York City. John Aballi, Exagen\u2019s President and Chief Executive Officer and Kamal Adawi, Exagen\u2019s Chief Financial Officer, will participate in a panel discussion on Tuesday, September 26th, at 8:45 AM ET. Interested parties may access the webcast of the presentation using a link on Exagen\u2019s website at https:\/\/investors.exagen.com\/events. About\u00a0Exagen Inc. Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of &hellip; Continue reading \"Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-12T22:07:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTAzOCM1ODExMTM0IzIwMTA5NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference","datePublished":"2023-09-12T22:07:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/"},"wordCount":180,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTAzOCM1ODExMTM0IzIwMTA5NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/","name":"Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTAzOCM1ODExMTM0IzIwMTA5NzI=","datePublished":"2023-09-12T22:07:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTAzOCM1ODExMTM0IzIwMTA5NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTAzOCM1ODExMTM0IzIwMTA5NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/783574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=783574"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/783574\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=783574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=783574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=783574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}